Ravi Sekhar Kasibhatta's Biography

Ravi Sekhar Kasibhatta, Senior Vice President, Lupin Ltd, India

Dr. Ravi Sekhar Kasibhatta is currently Sr. Vice President – Clinical Research at Lupin Bioresearch Center, Pune. Previously, held various positions at Dr.Reddy’s Laboratories, Hyderabad; Apl Research Center (Aurobindo Pharma), Hyderabad; Lambda Therapeutic Research, Ahmedabad; The Nizam’s Institute Of Medical Sciences, Hyderabad.
Dr Kasibhatta completed his Ph.D. in Pharmacology from Dept. of Clinical Pharmacology and Therapeutics of the Nizam’s Institute of Medical Sciences, Hyderabad, India and M.Sc. (Bio-Sciences) from Ravishankar University Raipur, M.P. (Now Chattisgarh), India
Dr Kasibhatta is currently heading Lupin Bioresearch Center to conduct in-vitro & in-vivo BA / BE & Clinical Equivalence Studies for Generic products, PK / PD studies of specialty products like Biosimilar, Inhalations products. He is a Clinical research professional having in-depth knowledge of Clinical, bioanalytical, pharmacokinetic & pharmacodynamics of pharmaceutical domain. Dr Kasibhatta has analytical and problem-solving skills, focussed approach, adaptive to the changing environment and progressive attitude with strong result orientation & timely deliverables.
He is a Team leader & Key member for CRO selection & qualification, cost-effective negotiations for Clinical program of Generic product program. He has proven expertise in establishing CROs, Bioanalytical & Clinical laboratories meeting the ISO standards, ICH-GCP compliance & other applicable international quality / regulatory standards. He is also acquainted with knowledge of latest analytical platforms like LC-MS/MS, IC, ELISA etc., and improved add-on services for Biosimilar, inhalations, derma programs and Biometrics for CT studies. Dr Kasibhatta has published around 33 papers in various national & international journals. He is currently overseeing 03 candidates for Ph.D. in biomedical / analytical sciences.

other conference

Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance
06 - 07 Nov, 2025

Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance

Details
Advances in CRISPR-Cas Genome Editing in Plants
10 - 12 Dec, 2025

Advances in CRISPR-Cas Genome Editing in Plants

Details
InjectablesX
29 - 30 Jan, 2026

InjectablesX

Details
whatsapp button